Chronic Abdominal Syndrome Due to Nervous Compression. Study of 100 Cases and Proposed Diagnostic-Therapeutic Algorithm by unknown
ORIGINAL ARTICLE
Chronic Abdominal Syndrome Due to Nervous Compression.
Study of 100 Cases and Proposed Diagnostic-Therapeutic
Algorithm
Francisco Javier Pérez Lara1 & J. Quintero Quesada2 & J. A. Moreno Ramiro3 &
R. Bustamante Toledo4 & A. Del Rey Moreno1 & H. Oliva Muñoz1
Received: 24 January 2015 /Accepted: 9 March 2015 /Published online: 24 March 2015
# 2015 The Author(s). This article is published with open access at Springerlink.com
Abstract
Objective In the medical literature, thoracic disc protrusion has traditionally been considered a rare occurrence. We hypothesise
that the incidence of such protrusions and their abdominal symptoms is higher than is generally believed and that their presence
may account for a significant proportion of chronic non-visceral abdominal pains. Accordingly, the present study was designed to
identify and quantify the symptoms experienced by patients with thoracic disc protrusion and to assess the relative risk of these
symptoms being presented, compared to the general population.
Design We conducted a cross-sectional study with a control group. The following comparison groups were analysed: case group,
consisting of 100 patients diagnosed with thoracic disc protrusion in our hospital between February 2007 and October 2012, and
control group consisting of 100 subjects from the general population, chosen at random. To compare the symptoms observed in
each group, the following tests were applied to all study subjects: clinical examination, gastrointestinal-related quality of life
(GIQLI) questionnaire and DN4 questionnaire. We also reviewed the subjects’ medical records for the previous 3 years.
Results The subjects in the case group had a significantly higher incidence of digestive-urologic symptoms, a poorer gastroin-
testinal quality of life and greater need of medical care than those in the control group. The differences were statistically
significant for all the parameters studied. Almost all the case group subjects suffered chronic abdominal pain and/or digestive-
urologic symptoms.We term this group of symptoms Bchronic abdominal syndrome due to nervous compression^. Nevertheless,
in most cases, no neurologic aetiology was suspected, and therefore the treatment given was ineffective. In view of the results
obtained, we propose a diagnostic-therapeutic algorithm for such patients.
Conclusion Thoracic disc protrusion, as well as having a non-negligible incidence, is often associated with a digestive-urologic
clinical syndrome, and this factor should be taken into account in all cases of chronic abdominal pain and other digestive-urologic
symptoms when standard tests are negative, so that appropriate treatment may be given.
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Introduction
Chronic abdominal wall pain is often mislabelled as being vis-
ceral in origin and so inappropriate complementary tests are
performed, unsatisfactory treatment is prescribed and unneces-
sary costs are incurred. The prevalence of this condition in
everyday medical practice is unknown, but some researchers
have estimated that it affects about 10 % of the patients pre-
senting with chronic idiopathic pain at a gastroenterology
consultation.1 Therefore, the early exclusion of a parietal cause
would increase diagnostic accuracy for these patients.
The dorsal roots facilitate abdominal cutaneous innervation
and visceral innervation of the colon, bladder and pelvic struc-
tures. Therefore, any dysfunction can produce abdominal pain
and gastrointestinal symptoms (diarrhoea, constipation, in-
creased peristalsis, abdominal pain, tenesmus, etc.), urologic
complaints (such as dysuria or polyaquiuria) and pain at di-
verse metameric levels (in the abdomen, pubis, groin, testicu-
lar area, trochanter, etc.).
It has traditionally been considered that the incidence of
thoracic disc protrusion (TDP) is very low, amounting to less
than 1 % of all disc protrusions.2 However, in recent years,
new diagnostic imaging methods have revealed otherwise; in
fact, the incidence of TDP is between 11 and 37 %.3
–7 Similar
findings have been reported from necropsy studies, according
to which the incidence may be as high as 10 % of the
population.8
Despite this high incidence, only 0.5–0.8 % of cases are
considered symptomatic.9
,10 On the other hand, it should also
be borne in mind that in most cases, only neurologic symptoms
are considered (no further examination is made as to whether
the patient has abdominal pain or digestive-urologic symp-
toms), and so when all of these symptoms are viewed jointly,
the percentage of symptomatic patients may be much higher.
Therefore, the problem could be addressed like this: neither
the orthopaedic surgeon nor the neurologist see patients with
chronic abdominal pain; on the other hand, the gastroenterol-
ogist, the gastrointestinal surgeon, the gynaecologist and the
urologist do see patients with chronic abdominal pain, but
they do not usually suspect the fundamental cause to be locat-
ed in the spine and therefore do not ask for magnetic reso-
nance imaging (MRI) of this area. In consequence, we are
faced with a pathology of a neurologic-traumatologic nature
but with gastrointestinal-urologic-gynaecologic symptoms,
which makes diagnosis very difficult. As a result, to date, this
body of symptoms has been considered to constitute a pathol-
ogy with a low incidence. However, we believe that what is
really infrequent is the diagnosis, not the condition.
Given these premises, in two recent papers11
,12, we pub-
lished the results of a two-phase study in which a spinal MRI
was performed on all patients attending our clinic with chronic
abdominal pain and symptoms (with criteria of parietal pain,
after the presence of an organic pathology had been rejected).
Of these patients 63.82 % (30 of 47) were found to have one or
more thoracic disc protrusions. In the above papers, we de-
scribed the symptoms of these patients and the results obtained
after specific treatment was prescribed for neuropathic pain.
Taking into account the above results, the aim of the pres-
ent study was to examine the syndrome complex presented by
100 patients with TDP, to assess whether they are being prop-
erly diagnosed and treated, to compare these patients with a
control group and, finally, to propose a diagnostic and thera-
peutic algorithm for this type of patient.
Material and Method
We conducted a cross-sectional study with a control group.
Thus, two groups of 100 subjects were compared: group 1
(cases) consisted of 100 patients diagnosed with TDP between
February 2007 and October 2012 in our hospital and group 2
(controls) consisted of 100 patients randomly selected from the
general population (that of the hospital district). Both groups
had similar characteristics in terms of sex (male/female 55/45
vs. 54/46, p=1) and age (52.48 vs. 50.15 years, p=0.316).
The study was approved by the research and ethics com-
mittee of our hospital. The subjects were informed about
the aims and procedures of the study, and those who agreed
to participate (cases: 100 of 145; controls: 100 of 135)
signed an informed consent form and underwent a clinical
test (Annex 1) to evaluate symptoms, diagnosis and treat-
ment results. They also completed the gastrointestinal-
related quality of life (GIQLI) questionnaire, either in the
hospital or sending it later, by post. Subjects with abdomi-
nal pain were also given a specific questionnaire (DN4) to
assess whether the pain was neuropathic in origin.
The GIQLI was presented in 1994 by Eypasch et al.13
,14
and it was translated into Spanish and validated in 2000.15
This questionnaire is a mixed type, between generic and spe-
cific, since it is used both to evaluate parameters related to the
overall quality of life and to examine those which relate spe-
cifically to the upper and lower gastrointestinal tract. It has
become increasingly popular in recent years, since it is simple
to administer and can be completed quickly and easily by the
subject, without expert assistance. It consists of 36 questions
organised into four dimensions: gastrointestinal symptoms,
emotional role (degree of tolerance to daily stress, depression,
stress, nervousness, fear, satisfaction with life and level of
frustration), physical status (tiredness, fatigue, illness, insom-
nia, abnormal changes in physical appearance, vitality, stami-
na and fitness) and social role (ability to perform daily living
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or recreational activities, changes in relationships with friends
and family, and sexual quality of life). Both the final result and
each of the dimensions are scored from 0 to 4 (with 0 being the
worst and 4 being the best score).
We used the DN4 questionnaire16 (Annex 2) to evaluate the
possible neuropathic aetiology of the abdominal pain. This
questionnaire consists of ten items grouped into four sections.
The first seven items are related to the nature of the pain
(burning, painful cold, electric shocks) and its association with
abnormal sensations (tingling, pins and needles, numbness,
itching). The other three items are related to the neurologic
examination in the area of pain (hypoesthesia to touch,
hypoesthesia to pricking, tactile allodynia). Each positive item
is scored 1 point and each negative item is scored 0. The total
score is calculated by summing the ten items, and the cutoff
value for the diagnosis of neuropathic pain is a total score
higher than 3.
The DN4 questionnaire was adapted into Spanish and its
psychometric properties (reliability and validity) were evalu-
ated by Pérez et al. 17 The questionnaire has a sensitivity of
87 % and a specificity of 84 %.
Finally, we reviewed the clinical record, for the previous
3 years, of the subjects in each group, including treatment at
the hospital’s emergency department, consultations with spe-
cialists, complementary tests performed and hospital
admissions.
These tests and the review of medical records enabled us to
evaluate the following parameters for the patients with TDP:
– Chronic pain, and its intensity, in the abdomen, back,
genitals and/or lower limbs (clinical test)
– Percentage of abdominal pain of a neuropathic nature
(DN4 questionnaire)
– Digestive-urologic symptomatology (clinical test)
– Gastrointestinal quality of life (GIQLI questionnaire)
– Need for emergency department treatment, consultation
with a specialist or hospital admission during the last
3 years (medical history)
– Percentage of patients whose symptoms were attributed
to TDP (clinical test)
– Medical treatment conducted (clinical test)
– Outcome of medical treatment conducted (clinical test)
We compared the results for these patients (cases) with
those for the randomly selected control group, to assess the
deterioration of gastrointestinal quality of life and the relative
risk of these patients presenting with the symptoms described,
with respect to the general population.
From the results obtained, and our experience with these
patients in previous studies, we will describe the clinical pic-
ture presented and the inclusion criteria applied. We will also
review recent literature in this respect and propose an algo-
rithm for diagnostic and treatment action.
Statistical Study
In a descriptive analysis of the study variables, the values of
the continuous variables are presented as the mean and the
corresponding standard deviation. Categoric variables are pre-
sented as absolute and relative frequencies. The results are
shown stratified by groups (case/control).
To test whether the data—the observed differences in the
frequencies of the variables of interest—are statistically sig-
nificant, Fisher’s test was used to assess the qualitative vari-
ables. In addition, the prevalence ratio was calculated, at a
95 % confidence interval.
To analyse the differences between the continuous quantita-
tive variables in two independent groups, Student’s t test was
applied for two independent samples. This was done assuming
the normal distribution of the variables in each group, whichwas
confirmed by the Shapiro-Wilk test. When non-normality was
observed, the Mann-Whitney non-parametric test was used.
The statistical analysis was performed by the FIMABIS
AMEC Unit, Málaga (Spain), with software R project version
3.0.3.
Results
The 100 subjects in the case group presented a total of 236
TDP. In 77 % of these, the subarachnoid space was occupied,
and in 8.89 %, there was contact with the bone, but only in
1.69 % was there injury to the nerve root. Of the protrusions,
70.76 % were below the T7 level (Fig. 1). The disc protrusion
was generalised in 10.59 % of cases, central in 65.25 %, right
paracentral in 7.2 % and left paracentral in 16.95 %.
Fig. 1 Location of disc herniations (case group)
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Of the subjects with TDP, 77 % had abdominal pain,
and of these, 16.88 % reported having had an operation to
relieve the pain (five cholecystectomies, three umbilical
hernia repai rs , one inguinal hern ia repai r, one
suprarenalectomy, one appendectomy, one hysterectomy,
one oophorectomy), but in all cases, the pain persisted
after surgery. In 50.64 % of cases, the patients commented
that the pain occurred when certain postures were
adopted, 49.35 % related it to physical effort and
12.99 % referred to a prior traumatic injury.
Of the patients in the case group, 95 % presented one or
more digestive-urologic symptoms, but only 3 % reported
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having had a diagnosis of TDP as the cause of their symptoms.
With respect to the medical treatment prescribed for their ab-
dominal pain, 25 % had not been given any treatment, 68 %
had been treated with NSAIDs and only 7 % had received
treatment for neuropathic pain (3 % stage 1, 2 % stage 2,
1 % stage 3 and 1 % stage 4).
In response to the question, BWhat changes have you no-
ticed after the treatment prescribed by your doctor?^, 8 % of
the patients stated that the pain had disappeared, 12 % had
obtained a significant improvement, 21 % had obtained a
moderate improvement, 31 % had obtained a slight improve-
ment and 28 % had obtained no improvement or a worsening
of the pain.
On comparing the two groups, we observed that both the
pain and the digestive-urologic symptoms were significantly
more frequent in the case group, with statistical significance in
all items (Table 1).
The subjects in the control group who had abdominal pain
reported it to be most frequently located in the central areas,
especially periumbilical locations (zone 5) (32 %), while in
the case group, the abdominal pain was most often located in
lateral and lower areas, especially in zone 7 (in the right iliac
fossa) (33 %).
Both the duration and the intensity of the pain (Table 2)
were greater in the case group, with statistical significance in
all locations.
Visits to the hospital’s emergency department, consul-
tation with specialists and hospital admissions in the
previous 3 years were all more numerous in the case
group, with statistical significance in the latter two cases
(Table 3).
The number of complementary tests performed in the pre-
vious 3 years (Table 4) was clearly higher in the case group,
with statistical significance in all items.
Table 2 Comparison of cases/controls: duration of pain and pain intensity in different areas
Mean cases SD cases Mean 
controls
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The gastrointestinal quality of life was significantly lower
in the case group, with statistical significance in all items
(Table 5).
Finally, 84.42 % of the subjects in the case group with
abdominal pain (n=77) had a positive result in the DN4 test,
with an average score of 4.27 (SD 2.1), However, among the
subjects with abdominal pain in the control group (n=25),
only 8 % had a positive result in this test. They had an average
score of 1 (SD 1.08), and the differences were statistically
significant with respect to positive test results (p=0.000) and
average score (p<0.001).
Discussion
Chronic abdominal pain, together with symptoms of gastroin-
testinal disturbances (of a non-organic nature), is commonly
encountered in current clinical practice and is normally classed
as idiopathic gastroparesis or functional disorder (irritable bow-
el syndrome or functional dyspepsia, among others).18
This problem continues to present a challenge to all cur-
rently known methods of diagnosis and treatment.19 Patients
usually consult various doctors and undergo multiple comple-
mentary tests, but in many cases, these fail to identify the
cause of the problem.
In 30 % of all patients with chronic abdominal pain, it is
located in the abdominal wall.20 The first reference to non-
visceral abdominal pain was made by Cyriax,21 who was con-
vinced that among a large number of patients, their abdominal
pain was not attributable to visceral causes.
However, it was Carnett, an English obstetrician, who first
attributed this pain to the structures of the abdominal wall, and
in 1926, he described the sign that bears his name, and which
remains in use today in clinical examination.22 This sign has a
sensitivity of 78–85 % and a specificity of 88–97 %.23 In this
procedure, the patient is placed in a supine position and the
abdomen is palpated to identify the area of greatest sensitivity
to pain. The patient is then asked to raise his head and shoul-
ders to facilitate the contraction of the abdominal muscles. If
the pain increases (or remains unchanged), its cause is most
likely in the abdominal wall and therefore the Carnett test
result is positive.24
The patient is not usually able to interpret the degree of
superficiality of the pain, and therefore the physician must
take into account the clinical history and perform a careful
examination in order to determine the metameric source
of the pain. An algorithm for evaluating chronic abdomi-
nal pain, using Carnett’s sign and the infiltration of the
trigger points (if the pain decreases when the point of
maximum pain is infiltrated, the sign is positive), has
been suggested by Gallegos and Hobsley25 and was used
by Greenbaum et al.24
In a study conducted by Constanza et al. of physicians
treating patients with chronic abdominal pain, only 4 % of
Table 3 Comparison of cases/controls: medical attention required in the last 3 years
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respondents considered pain originating in the abdominal wall
as an initial diagnostic possibility.26 This finding coincides
with our own results, in which in only 3 % of patients was
the pain attributed to a disc pathology.
Gómez Rodríguez et al.27 reported that when abdomi-
nal pain of unknown aetiology is persistent, this leads to
multiple examinations—both time- and labour-intensive—
being conducted, and if a small anomaly is found, it can
sometimes lead to unnecessary surgery being performed,
especially in gynaecological medicine. This is corroborat-
ed by our own results, according to which the patients in
the case groups underwent a large number of additional
tests, specialist consultations and hospital admissions, in
comparison with the general population, and 16.88 % of
these patients were operated for pathologies unrelated
with the metameres of the abdominal wall, and unsuccess-
fully in every case.
Since symptomatic TDP was first described by Key in
1938, this uncommon pathology has posed a challenge to
spinal surgeons.28 Both diagnosis and treatment are controver-
sial due to the low prevalence described, the wide variety of
clinical presentations and conflicting definitions of discal
symptoms.29
Visceral and somatic afferent fibres in the dorsal columns,
spinothalamic and spinocerebellar tracts and the dorsal and
ventral horns have been observed at different levels of the
spine.30
–32 The irritation of these tracts, and the fact of their
close association with the dorsal grey column of the spinal
cord, can cause pain and discomfort.31 Rohde and Kang pro-
posed that compression of the cord at the site of visceral af-
ferent fibres can lead to inflammation and hyperexcitability of
the visceral neurons.30 This might interfere with the descend-
ing inhibitory fibres that modulate noxious input and thus
provoke atypical presentations of TDP. This would account
Table 4 Comparison of cases/controls: complementary tests in the last 3 years
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for the clinical variability found in our study (cases with bilat-
eral pain, cases with an evident visceral association and cases
with lesions higher than the T7 level but presenting abdominal
pain).
In agreement with our results, Arce and Dohrmann5 report-
ed that 75 % of TDP occur below T8, 3 % between T1 and T2
and less than 1 % between T2 and T3. As regards the area of
the disc that is affected, central protrusions are the most
common.33 This condition is observed more frequently in
middle-aged and older patients, and there are no signifi-
cant differences with respect to gender.34
,35 Although disc
degeneration is the primary factor, trauma is also of con-
siderable importance, being recorded in up to 25 % of
cases.5
,33 Nevertheless, in our study, only 12 % of the
patients in the case group had a trauma event in their
clinical history. Genetic factors have also been suspected
as a possible cause.36
From our review of the medical literature in this respect,
we conclude that in most cases, symptomatic TDP has a
mild to moderate clinical impact, producing thoracic or
abdominal pain, sensory disturbances37
,38 and, less fre-
quently, myelopathy and weakness of the lower limbs.39
Other gastrointestinal, urologic and cardiopulmonary
symptoms have also been described.40
,41 This varied set
of clinical presentations cannot be correlated with the lo-
cation of the hernia, and so patients are often misdiagnosed
by their primary care physicians, which gives rise to ex-
tensive and costly tests being performed.42 If the patient is
referred to a specialist (normally a gastroenterologist, gas-
trointestinal surgeon, urologist or gynaecologist), a disor-
der of a neurologic nature is unlikely to be suspected. In
consequence, TDP has traditionally been considered a very
uncommon disease (one case per million inhabitants per
year2).
However, recent necropsy studies of the spine have sug-
gested that the prevalence may be as high as 10%.8Moreover,
new imaging techniques have detected TDP in 11–37% of the
population3
–7 and 39 % of cases have more than one
herniation.6
This strongly suggests that we are facing a disease with
a high incidence among the population, and therefore
many patients are currently undiagnosed. For example,
in the catchment area for our hospital, with a population
of about 100,000, according to the above studies, there
must be between 10,000 and 37,000 people with TDP.
The question then arises: what percentage of these people
present well-developed abdominal pain with gastrointesti-
nal, gynaecologic or urologic symptoms and yet are undi-
agnosed and therefore not being treated properly? To put
it another way, how many patients with chronic abdomi-
nal pain and symptoms, in cases in which organic pathol-
ogy has been excluded, and who are normally classified
Table 5 Comparison of cases/controls: GIQLI questionnaire
1.0
Symptoms Emotional Physical Social
Mean control s SD control s Mean case s SD cases p 
Symptoms 3.26 0.47 2.63 0.52 <0.0000
Emotional 2.94 0.68 2.1 0.81 <0.0000
Physical 2.89 0.85 1.74 0.91 <0.0000
Social 3.25 0.8 2.2 0.95 <0.0000
TDP
RP
SD standard deviation, TDC thoracic disc protrusion, RP random population
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as suffering irritable bowel syndrome or a functional pa-
thology, might actually be suffering a thoracic spine pa-
thology, which is the true cause of their condition?
Answers to these questions can only be properly obtained
by carrying out a prospective multicentre study with a
large number of patients. Contrary to the findings of pre-
vious research in this field, our study shows that patients
with TDP very often suffer abdominal pain (77 %), ac-
companied by digestive-urologic symptoms (95 %) and a
significant deterioration in their gastrointestinal quality of
Chronic abdominal pain 
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Fig. 2 Diagnostic and
therapeutic algorithm
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life. It seems, therefore, that a significant number of pa-
tients could benefit from the diagnostic and therapeutic
algorithm proposed in this study.
When we asked our patients with TDP about the diag-
nosis they had been given, only 3 % mentioned neuro-
pathic pain. In view of the long-standing nature of the
condition (mean duration 50 months) and the fact that
most of these patients had not received a definitive diag-
nosis, there remains an important knowledge gap to be
filled. In addition, it should be taken into account that
25 % of these patients were not treated and that 68 %
had had a treatment that did not correspond to the scale
of neuropathic pain. Furthermore, only 20 % reported be-
ing pain-free or having achieved a significant improve-
ment after treatment. It must be concluded that a large
portion of these patients were inadequately treated; no
aetiological diagnosis of nervous compression was made,
and therefore the outcome was unsatisfactory. In our pre-
vious two studies, when patients were diagnosed with disc
pathology as being responsible for the pain, this was treat-
ed by considering the neuropathic pain scale, and the pain
was reduced or significantly alleviated in 61.11 and
53.33 % of cases, respectively.
Taking into account the data obtained in the present
study and the findings of previous research by our group,
we term the symptoms presented by these patients
Bchron ic abdomina l syndrome due to nervous
compression^ (CASNC). We define this syndrome as
one in which there is chronic abdominal pain, often ac-
companied by back pain and digestive-urologic symp-
toms, with no apparent cause of an organic nature being
revealed by the complementary tests; moreover, TDP has
been observed and at least one of the following criteria is
met:
– Carnett’s sign +
– Trigger point infiltration +
– DN4 questionnaire +
The ideal treatment for neuropathic pain would be to
address and resolve its cause. However, this is often not
possible, and when it is undertaken, the pain may only
be alleviated in part or even not at all. In such cases,
excepting the peculiarities of very specific types of pain,
the pharmacologic treatment of neuropathic pain is car-
ried out in stages, using different pharmacologic groups.
In our opinion, this is the approach that should be
followed in patients diagnosed with CASNC. However,
there is no consensus as to the drugs that should be
employed at each stage, and CASNC patients form a
highly specific group. Therefore, we decided to adapt
the pain scale for the treatment of CASNC taking into
account our own previous studies and the latest
guidelines for the treatment of neuropathic pain (pub-
lished by the International Association for the Study of
Pain, the Neuropathic Pain Special Interest Group, the
European Federation of Neurological Societies and the
Canadian Pain Society), together with recent studies in
this respect.43
–55 Finally, taking into account these con-
siderations, we propose a diagnostic and therapeutic al-
gorithm (Fig. 2) for all patients with TDP and chronic
abdominal pain or gastrointestinal-urologic symptoms
and for whom conventional diagnostic methods have
ruled out the presence of an organic pathology.
Conclusion
In summary, both TDP and its symptoms are much more
common than has been thought. The majority of these
patients present a long-standing clinical situation, with
pain in the back (90 %), abdomen (77 %) or other loca-
tions (pubis 43 %, genital area 35 %, lower limbs 66 %),
always at a considerable level of intensity and frequently
accompanied by digestive-urologic symptoms (95 %).
These symptoms provoke a significant deterioration in
the gastrointestinal quality of life and lead patients to
be offered a large number of complementary tests, con-
sultations with specialists and even hospital admission.
Nevertheless, after all these studies, the patients’ condi-
tion is usually summarised as being of a functional na-
ture, and so inadequate treatment is provided and the
results obtained are unsatisfactory.
As treatment strategies vary according to whether the pain
is nociceptive or neuropathic, it is important to identify the
neuropathic component, even when the pain is heterogeneous.
Therefore, the possible presence of CASNC should be con-
sidered in all cases of chronic abdominal pain and symptoms
with negative test results, so that appropriate treatment may be
given.
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Annex 1
Table 6 Clinical test
Please answer concerning symptoms that occur with more or less regularity (not symptoms that occur only once):
1- Do you often have abdominal pain? If so, show on the drawing where you feel it, and then answer questions 2, 3, 4 and 5:
2- On the scale below, mark the intensity of the pain (0 = no pain; 10 = the worst pain imaginable)
How often does the pain occur?
- Every day
- Every other day
- Once a week
- Once a month
- Every few months
3- Does it tend to occur when you make a physical effort?
4- Did the pain begin following a physical impact? If so, what part of our body was affected?
5- Does the pain occur when you are in a stressful position? (for example, leaning forward for a prolonged period)
6- Do you have (or have you had) problems urinating? (if so, please specify)
- Pain or burning
- Difficulty
- The  need to urinate very often, but only a small amount
7- Do you have (or have you had) an evident increase in intestinal noises and/or gases? 
8- Do you have (or have you had) appreciable pain in your diaphragm?
9- Do you sometimes have an urgent need to go to the toilet?
10- Have you lost weight recently?
11- Do you often have (or have you had) diarrhoea or constipation, or an alteration  in how often you go to the toilet? 




12- Do you often have (or have you had) difficulty in breathing because of the pain? 
13- Do you often have (or have you had) pain in your back? 
If so, on the scale below, mark the intensity of the pain (0 = no pain; 10 = the worst pain imaginable)
How often does the pain occur?  
- Every day
- Every other day
- Once a week
- Once a month
- Every few months
14- Do you often have (or have you had) pain in the groin area?
If so, on the scale below, mark the intensity of the pain (0 = no pain; 10 = the worst pain imaginable)
How often does the pain occur?  
- Every day
- Every other day
- Once a week
- Once a month
- Every few months
15- Do you often have (or have you had) pain in your legs? 
If so, on the scale below, mark the intensity of the pain (0 = no pain; 10 = the worst pain imaginable)
How often does the pain occur?  
- Every day
- Every other day
- Once a week
- Once a month
- Every few months
16- Do you often have (or have you had) pain in your genitals?
If so, on the scale below, mark the intensity of the pain (0 = no pain; 10 = the worst pain imaginable)
How often does the pain occur?  
- Every day
- Every other day
- Once a week
- Once a month
- Every few months
17- Do you often have (or have you had) pins and needles? 







How often does this occur?  
- Every day
- Every other day
- Once a week
- Once a month
- Every few months
- Other (specify) 
18- How long have you been having this pain (months)?
19- What changes have you noted since treatment began? 




- No improvement/ Worse
20- Have you been operated on for anything since the pain began? (if so, specify)
21- If you have been operated on, was it because of the pain?
22- What diagnosis were you given concerning the pain?
23- If you have any other symptom, please describe it briefly.
1     2     3
4     5     6
7     8     9
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Annex 2
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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